Table 2.
Protocol specificities between coordinating sites
| Characteristic | Valencia, Spain | St. Petersburg, Russia | Moscow, Russia | Turkey | France |
|---|---|---|---|---|---|
|
Hospitals |
5 health care district general hospitals |
1 infectious disease hospital, 1 children’s city hospital, 1 children’s infectious disease hospital |
1 infectious disease hospital |
7 general hospitals |
5 university hospitals |
|
Screening ward |
Emergency |
Emergency and 3 selected wards |
Paediatric, mixed, pregnancy, adults |
Emergency and 7 selected wards |
Emergency and >20 selected wards |
|
Screening diagnosis |
Admission diagnosis associated with influenza infection; clinical symptoms of ILI |
Clinical symptoms of ILI |
Admission diagnosis associated with influenza inflection; clinical symptoms of ILI |
Clinical symptoms of ILI |
Signs of respiratory illness for <7 days |
|
Recruited by |
Full-time trained nurses |
Doctors |
Doctors, nurses, heads of wards |
Doctors |
Doctors, clinical researchers, nurses |
|
Additional exclusion criteria |
Outside catchment area |
- |
- |
- |
Not affiliated with social security |
|
Study start criteria |
2 consecutive weeks with ≥2 cases |
Week with ≥5 laboratory-confirmed influenza cases using national surveillance data |
Week with ≥5 laboratory-confirmed influenza cases using national surveillance data |
Not defineda |
Defined by the national surveillance system |
|
Study end criteria |
2 consecutive weeks with no cases |
Week with no laboratory-confirmed influenza cases |
Week with no laboratory-confirmed influenza cases |
Not defineda |
Defined by the national surveillance system |
| Actual study period (epidemiological weeks) | 2013-01 – 2013-15 | 2013-03 – 2013-22 | 2013-02 – 2013-21 | 2013-01 – 2013-14 | 2012-51 – 2013-16 |
aStudy period not defined because it was a pilot study. Cases of ILI were reported between epidemiological weeks 1 and 14 of 2013.
Dashes indicate no additional exclusion criteria.